Was the 1,024-share disposition by Denise Zamore in agilon health (AGL) an open-market sale?

No. The 1,024 shares of Common Stock were withheld by agilon health to satisfy income tax withholding and remittance obligations from restricted stock unit settlement. A footnote clarifies this withholding does not represent a sale in the open market by Denise Zamore.

[Form 4] agilon health, inc. Insider Trading Activity

Q: What insider transactions did agilon health (AGL) report for Denise Zamore?

Denise Zamore reported a grant of 50,000 shares of Common Stock as equity compensation and the withholding of 1,024 shares to cover income taxes. These transactions were routine, compensation-related events rather than open-market purchases or sales of agilon health stock.

Q: What are the terms of Denise Zamore’s restricted stock units at agilon health (AGL)?

Her restricted stock units vest in three equal installments on each anniversary of April 1, 2026 , subject to continued employment. The Form 4 notes that her reported beneficial ownership figure includes these restricted stock units as part of her total equity position.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

agilon health, inc. Chief Legal Officer Denise Zamore reported routine equity compensation and related tax withholding. She received a grant of 50,000 shares of Common Stock on a grant/award basis, increasing her direct beneficial ownership to 66,837 shares, which includes restricted stock units.

On the same date, 1,024 shares of Common Stock were withheld by the company at $9.75 per share to cover income tax obligations from the net settlement of restricted stock units, and this did not represent an open-market sale. The filing notes a 1-for-25 reverse stock split of agilon health’s common stock effective March 30, 2026, and states that the reported holdings reflect this adjustment. The restricted stock units vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Zamore Denise

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,024	$9.75	$10K
Grant/Award	Common Stock	50,000	$0.00	--

Holdings After Transaction: Common Stock — 16,837 shares (Direct)

Footnotes (1)

Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. Includes restricted stock units.

Form 4 Insider Transactions: What Each Field Means →

04/03/2026 - 07:36 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zamore Denise

(Last)

(First)

(Middle)

C/O AGILON HEALTH, INC.

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE

OHIO

43082

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/01/2026		F		1,024⁽¹⁾	D	$9.75	16,837⁽²⁾	D
Common Stock	04/01/2026		A		50,000⁽³⁾	A	$0	66,837⁽⁴⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.

2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

3. Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.

4. Includes restricted stock units.

Remarks:

	/s/ Mimi Yang, as Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did agilon health (AGL) report for Denise Zamore?

Denise Zamore reported a grant of 50,000 shares of Common Stock as equity compensation and the withholding of 1,024 shares to cover income taxes. These transactions were routine, compensation-related events rather than open-market purchases or sales of agilon health stock.

How many agilon health (AGL) shares does Denise Zamore hold after this Form 4?

Following the reported transactions, Denise Zamore beneficially owns 66,837 shares of Common Stock, including restricted stock units. This post-transaction figure already reflects agilon health’s 1-for-25 reverse stock split of its issued and outstanding common stock effective March 30, 2026.

What are the terms of Denise Zamore’s restricted stock units at agilon health (AGL)?

Her restricted stock units vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. The Form 4 notes that her reported beneficial ownership figure includes these restricted stock units as part of her total equity position.

How did agilon health’s reverse stock split affect the holdings in this Form 4?

The filing explains that the beneficial ownership amounts, including the 66,837 shares reported for Denise Zamore, reflect a 1-for-25 reverse stock split of agilon health’s issued and outstanding common stock that became effective on March 30, 2026.

What do the transaction codes F and A mean in the agilon health (AGL) Form 4?

Code F indicates shares withheld to pay exercise price or tax liabilities, here 1,024 shares for income taxes. Code A denotes a grant or award acquisition, in this case a 50,000-share common stock grant to Denise Zamore as compensation.